The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs ...

The Centers for Medicare and Medicaid Services has confirmed the standard monthly premium will rise to $202.90 next year.

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

In mid-June, the Medicare Trustees Report had estimated the Part B premium would rise by a scorching-hot 11.5% to $206.20 per ...

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

As Trump takes a victory lap on lower drug prices, he should thank Biden for signing a key law that made it possible.

The monthly premium for Medicare Part B will rise significantly next year from $185 a month in 2025. Here's what it means for ...

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...